The American College for Advancement in Medicine’s (ACAM) 63rd International Educational Symposium on Complementary, Alternative and Integrative Medicine (CAIM) was held on May 18–22, 2005 at Disney’s Coronado Springs Resort in Orlando, FL, USA. ACAM’s scientific symposium brought together physicians and scientists from 13 countries for a comprehensive educational program on the evaluation and treatment of age-associated hormone deficiency with special attention to the use of bioidentical hormones in andropause and menopause.
ACAM’s Spring 2005 convocation, entitled ‘Menopause, Andropause: Power in Transition’, addressed a multitude of topics relevant for physicians and scientists interested in improving their understanding of safe and effective hormone replacement therapy, nutritional intervention and the lifestyle modifications needed in order to ensure healthier and longer lives as our population transitions into middle age. The scientific presentations focused upon the use of bioidentical hormone supplementation for the treatment of aging and a wide variety of illnesses. Keynote presentations highlighted the adverse consequences of endocrine disrupting chemicals on human health along with recent advances in predictive genomics testing for evaluating both risks and benefits of hormone replacement therapy. Evidence-based protocols were presented for the use of bioidentical hormones in the treatment of disorders of the endocrine, reproductive and cardiovascular systems.
As a growing body of research has demonstrated a significant increase in disease risk in menopausal women taking conventional non-bioidentical hormone replacement therapy (1,2), the conference served as a testament to the overwhelming professional interest in the use of bioidentical hormones and CAIM therapies for treating disorders of hormonal senescence.
1. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. J Am Med Assoc. 2003;290:1729–38. [PubMed]
2. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. J Am Med Assoc. 2000;288:321–33. [PubMed]
For a summary of the proceedings go to: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1193553/#!po=97.6190